9MW0311: Clinical Trials

1 trial of 9MW0311, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow 9MW0311: new trials by email Literature Review of 9MW0311 trials Research Report on 9MW0311

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
9MW0311, Prolia® - Postmenopausal Women Osteoporosis
Phase 3CompletedMabwell (Shanghai) Bioscience Co., Ltd.2802024-11-162026-08-07

Sponsors

Mabwell (Shanghai) Bioscience Co., Ltd. (1)

Countries

China (1)